Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Comparative docking study of the ligand to the target

From: Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment

Ligand Protein No. of H bonds Interacting residues
6′-Methyl-Thiamin Diphosphate Transketolase 5 His 109, Asn 108, His 515,